跳转至内容
Merck
CN
  • [Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].

[Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].

Deutsche medizinische Wochenschrift (1946) (2014-07-30)
Dorothea Baumann, Michael Haap, Christos Tsaousidis, Bernhard Krämer, Jürgen Schreieck, Karl Jaschonek, Ingo Rettig, Andreas Peter, Diethelm Wallwiener, Ferruh Artunc
摘要

A 90-year-old female patient treated with dabigatran for atrial fibrillation presented emergently with a spontaneous vaginal bleeding due to endometrium carcinoma. Laboratory analysis revealed azotemia consistent with acute-on-chronic renal failure. Coagulation was deranged (prolongation of activated partial thromboplastin time (aPTT) by 3.5-fold, international normalized ratio (INR) 7.8) due to a massive accumulation of dabigatran (measured plasma concentration 2230 ng/ml). Vaginal bleedings were treated with external tamponade. Hemodialysis treatment was commenced due to uremia and dabigatran accumulation. Over night, the patient was dialysed with a SLED (sustained low efficiency dialysis) regimen. After volume resuscitation renal function promptly ensued indicating prerenal azotemia as a cause of renal failure. After two more hemodialysis sessions dabigatran concentrations were no longer detecable and this was paralleled by normalization of coagulation tests. Dabigatran can accumulate massively during acute renal failure and evoke a life-threatening bleeding diathesis. Dabigatran can be removed with low efficient dialysis (such as SLED).

材料
产品编号
品牌
产品描述

Sigma-Aldrich
β-丙氨酸, 99%
Sigma-Aldrich
β-丙氨酸, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
β-丙氨酸, BioXtra, ≥99.0% (NT)
Supelco
β-丙氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
β-丙氨酸, analytical standard
Sigma-Aldrich
β-丙氨酸, BioUltra, ≥99.0% (NT)